SCHEMBL30337182

SCHEMBL30337182

Cn1cc(-c2ccnc(I)n2)c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 3/20 0.51
CDK5R1 Q15078 3/20 0.51
MKNK1 Q9BUB5 1/20 0.50
MKNK2 Q9HBH9 1/20 0.50
EGFR P00533 5/20 0.49
DYRK1A Q13627 2/20 0.48
FLT3 P36888 1/20 0.46
IMPDH2 P12268 1/20 0.46
HDAC1 Q13547 2/20 0.45
KDM4E B2RXH2 2/20 0.45
NPC1 O15118 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
HTT P42858 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28987594 1.00 CDK5 (0.51) CDK5CDK5R1MKNK1MKNK2EGFR
SCHEMBL28939744 0.82 EGFR (0.52) CDK5CDK5R1MKNK1MKNK2EGFR
SCHEMBL29419125 0.82 MKNK1 (0.50) CDK5CDK5R1MKNK1MKNK2EGFR
SCHEMBL5096322 0.82 MKNK1 (0.50) CDK5CDK5R1MKNK1MKNK2EGFR
SCHEMBL5750318 0.82 CDC7 (0.60) CDK5CDK5R1MKNK1MKNK2EGFR
SCHEMBL29800582 0.82 EGFR (0.52) CDK5CDK5R1MKNK1MKNK2EGFR
SCHEMBL29870510 0.82 CDC7 (0.60) CDK5CDK5R1MKNK1MKNK2EGFR
SCHEMBL17490423 0.82 MKNK1 (0.47) CDK5CDK5R1MKNK1MKNK2EGFR
Hydrochloric Acid SCHEMBL5749287 0.81 CDC7 (0.59) CDK5CDK5R1MKNK1MKNK2EGFR
SCHEMBL30219257 0.81 DYRK1B (0.54) CDK5CDK5R1MKNK1MKNK2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974845-B Preparation method of Ornitinib intermediate 奥锐特药业股份有限公司 2024-09-20 CN disclosed
CN-115974845-A Preparation method of oxitinib intermediate 奥锐特药业股份有限公司 2023-04-18 CN disclosed